Star Health schedules analyst meets on May 27

0 min read Updated on 22 May 2026, 04:13 AM

Reviewed by

Jubin VScanX News Team

AI Summary

Star Health and Allied Insurance Company Limited will hold analyst and institutional investor meetings on May 27, 2026, in Bengaluru. The schedule includes in-person sessions with Tunga Investments and True Beacon. The company has provided a link to the presentation and noted that the meetings are subject to change.

*this image is generated using AI for illustrative purposes only.

Star Health and Allied Insurance Company Limited has announced it will hold meetings with analysts and institutional investors on May 27, 2026, in Bengaluru. The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company has scheduled two in-person sessions with specific firms. The first meeting is with Tunga Investments, followed by a session with True Beacon. The company noted that these meetings are subject to changes due to exigencies on the part of the analysts or investors.

The schedule for the meetings is detailed below:

Sr No	Firm	Mode	Time
1	Tunga Investments	In-person	10:00 AM – 11:00 AM
2	True Beacon	In-person	1:00 PM – 2:00 PM

A presentation regarding the meeting has been made available online. Additionally, the disclosure and related information will be accessible on the company's official website. The communication was signed by Jayashree Sethuraman, Company Secretary & Compliance Officer.

Historical Stock Returns for Star Health Insurance

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.72%	+3.13%	+1.71%	+6.40%	+19.56%	-42.34%

What strategic updates or financial guidance might Star Health reveal to institutional investors that could influence its stock performance in the near term?

How might the insights shared with Tunga Investments and True Beacon shape their investment positions in Star Health, potentially signaling broader institutional sentiment toward the health insurance sector?

Given Star Health's recent business challenges, including data breaches and leadership changes, what key concerns are institutional investors likely to raise during these meetings?

Premium Target and Geographic Strategy

As part of its medium-term growth roadmap, Star Health and Allied Insurance has set a gross written premium target of ₹24,000 crore by FY27. The company's strategy to source the majority of its business from smaller cities reflects a deliberate effort to diversify its revenue base and reach customers in Tier-2, Tier-3, and smaller urban centres across the country.

The following table summarises the key strategic parameters announced by the company:

Parameter:	Details
Premium Target:	₹24,000 crore
Target Year:	FY27
Business from Smaller Cities:	65%
New Product:	'Value Plus' Health Insurance

New Product: 'Value Plus'

Alongside its geographic expansion plans, Star Health and Allied Insurance is introducing a new health insurance product named 'Value Plus'. The launch of this product is aimed at strengthening the company's offerings and catering to a broader customer base, particularly in markets where affordability and value-driven propositions are key purchase drivers.

Key Strategic Highlights

The company's announced strategy can be summarised through the following key focus areas:

Geographic Diversification: Target of generating 65% of business from smaller cities
Premium Growth: Gross written premium target of ₹24,000 crore by FY27
Product Expansion: Introduction of the new 'Value Plus' health insurance product

Star Health and Allied Insurance's strategy reflects a clear emphasis on broadening its market reach while simultaneously enhancing its product suite. The combination of a defined premium target, a geographic focus on smaller cities, and a new product launch outlines the company's approach to sustaining growth momentum in the health insurance segment.

Historical Stock Returns for Star Health Insurance

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.72%	+3.13%	+1.71%	+6.40%	+19.56%	-42.34%

How will Star Health's distribution infrastructure and agent network need to scale to effectively penetrate Tier-2 and Tier-3 cities, and what investments are planned to support this expansion?

Could the 'Value Plus' product's affordability-focused pricing strategy impact Star Health's overall claims ratio and profitability margins in smaller city markets?

How might Star Health's aggressive geographic expansion into smaller cities affect its competitive positioning against public sector insurers like National Insurance and New India Assurance, which already have strong rural and semi-urban presence?